← Back to Search

My Sentence Builder for Language Disorder

N/A
Recruiting
Led By Karla N Washington, PhD
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ages 48-71 months
Monolingual and native Standard English speakers
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-to-post (up to 14 weeks), post-to-followup (at 27 to 28 weeks)
Awards & highlights

Study Summary

This trial uses neuroimaging and behavioral methods to study the memory-language mechanisms that underlie grammar learning and impairment in children with developmental language disorders, in order to informing the design of more individualized interventions.

Who is the study for?
This trial is for preschoolers aged 4 to almost 6 with developmental language disorders affecting their grammar. They must speak only English, have normal hearing and vision (with correction), average nonverbal IQ, and no other interventions or special education for communication issues. Kids who can't safely undergo an MRI are excluded.Check my eligibility
What is being tested?
'My Sentence Builder' is being tested in this study to see if it helps improve grammar in children with developmental language disorders. The research includes brain scans (neuroimaging) and behavior tests to understand how the treatment might cause changes in the brain related to language learning.See study design
What are the potential side effects?
Since 'My Sentence Builder' is a non-medical intervention focusing on language skills, there are no direct medical side effects expected from this treatment as typically associated with drug trials.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 4 and 6 years old.
Select...
I speak only English and it's my first language.
Select...
I have been diagnosed with DLD affecting my ability to use grammar.
Select...
My child is between 4 and 6 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-to-post (up to 14 weeks), post-to-followup (at 27 to 28 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-to-post (up to 14 weeks), post-to-followup (at 27 to 28 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Functional connectivity data (time 1) from typical and DLD preschoolers
Functional connectivity data DLD preschoolers only to assess changes with treatment
Functional connectivity data for typically developing and DLD preschoolers to assess changes in development
Secondary outcome measures
Percent correct on a grammar screener for DLD preschoolers only to identify treatment targets
Percent correct on a grammar task for DLD preschoolers only
Percent correct on a grammar task for typically developing and DLD preschoolers to assess development and disorder.
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TreatmentExperimental Treatment1 Intervention
computer assisted intervention targeting expressive grammar for preschoolers with DLD
Group II: No treatmentActive Control1 Intervention
business as usual classroom (educational) services

Find a Location

Who is running the clinical trial?

University of TorontoOTHER
694 Previous Clinical Trials
1,019,962 Total Patients Enrolled
1 Trials studying Language Developmental Disorders
45 Patients Enrolled for Language Developmental Disorders
University of CincinnatiLead Sponsor
430 Previous Clinical Trials
634,307 Total Patients Enrolled
1 Trials studying Language Developmental Disorders
45 Patients Enrolled for Language Developmental Disorders
Children's Hospital Medical Center, CincinnatiOTHER
815 Previous Clinical Trials
6,530,486 Total Patients Enrolled
1 Trials studying Language Developmental Disorders
45 Patients Enrolled for Language Developmental Disorders

Media Library

My Sentence Builder Clinical Trial Eligibility Overview. Trial Name: NCT05268341 — N/A
Language Developmental Disorders Research Study Groups: Treatment, No treatment
Language Developmental Disorders Clinical Trial 2023: My Sentence Builder Highlights & Side Effects. Trial Name: NCT05268341 — N/A
My Sentence Builder 2023 Treatment Timeline for Medical Study. Trial Name: NCT05268341 — N/A
~90 spots leftby Jun 2026